Calidi Biotherapeutics
CLDI
CLDI
40 hedge funds and large institutions have $202M invested in Calidi Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and closing their positions.
Holders
40
Holders Change
+13
Holders Change %
+48.15%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
4
Closed
–
Calls
$599K
Puts
–
Net Calls
+$599K
Net Calls Change
+$5K
Top Buyers
| 1 |
6CM
1
683 Capital Management
New York
|
$11.9M |
| 2 |
SCM
2
Shaolin Capital Management
Miami,
Florida
|
$11.6M |
| 3 |
AC
3
Aristeia Capital
Greenwich,
Connecticut
|
$9.79M |
| 4 |
4
Millennium Management
New York
|
$4.89M |
| 5 |
5
Nomura Holdings
Tokyo,
Japan
|
$1.84M |
Top Sellers
| 1 |
HCM
1
Highbridge Capital Management
New York
|
$5.53M |
| 2 |
AMH
2
Apollo Management Holdings
New York
|
$19.1M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$15K |
| 4 |
AA
4
AQR Arbitrage
Greenwich,
Connecticut
|
$401K |
